YASMIN

YASMIN

Marketed by: Bayer Oy
Active ingredient: Drospirenonum,Ethinylestradiolum
Other information: film-coated tablet - 0.03 mg / 3 mg

Available in: Finland
Language: English
Source: Fimea

YASMINELLE

YASMINELLE

Marketed by: Bayer Oy
Active ingredient: Ethinylestradiolum betadex-clathratum,Drospirenonum
Other information: film-coated tablet - 0.02 mg / 3 mg

Available in: Finland
Language: English
Source: Fimea

YAZ

YAZ

Marketed by: Bayer Oy
Active ingredient: Ethinylestradiolum betadex-clathratum,Drospirenonum
Other information: film-coated tablet - 0.02 mg / 3 mg

Available in: Finland
Language: English
Source: Fimea

YERVOY

YERVOY

Marketed by: Bristol-Myers Squibb Pharma EEIG
Active ingredient: EU/1/11/698/001-002
Other information: concentrate for solution for infusion - 5 mg/ml

Available in: Finland
Language: English
Source: Fimea

YAMOXICLAV

YAMOXICLAV

Marketed by: Astellas Pharma Europe B.V.
Active ingredient: Kalii clavulanas,Amoxicillinum trihydricum
Other information: dispersible tablet - 875 mg / 125 mg

Available in: Finland
Language: English
Source: Fimea

YAMOXICLAV ASTELLAS EUROPE

YAMOXICLAV ASTELLAS EUROPE

Marketed by: Astellas Pharma Europe B.V.
Active ingredient: Kalii clavulanas,Amoxicillinum trihydricum
Other information: dispersible tablet - 875 mg / 125 mg

Available in: Finland
Language: English
Source: Fimea

YAMOXICLAV ASTELLAS

YAMOXICLAV ASTELLAS

Marketed by: Astellas Pharma Europe B.V.
Active ingredient: Amoxicillinum trihydricum,Kalii clavulanas
Other information: dispersible tablet - 875 mg / 125 mg

Available in: Finland
Language: English
Source: Fimea

YASNAL

YASNAL

Marketed by: Miklich Laboratorios S.L.
Active ingredient: Donepezili hydrochloridum monohydricum
Other information: film-coated tablet - 5 mg

Available in: Finland
Language: English
Source: Fimea

YASNAL

YASNAL

Marketed by: Miklich Laboratorios S.L.
Active ingredient: Donepezili hydrochloridum monohydricum
Other information: film-coated tablet - 10 mg

Available in: Finland
Language: English
Source: Fimea

YOMESAN

YOMESAN

Marketed by: Bayer AG
Active ingredient: Niclosamidum
Other information: tablet - 500 mg

Available in: Finland
Language: English
Source: Fimea

YOHIMBINI VET

YOHIMBINI VET

Marketed by: Orion Oyj
Active ingredient: Yohimbini hydrochloridum
Other information: tablet - 100 mg

Available in: Finland
Language: English
Source: Fimea

YTTRIUM Y-90 SILICATE

YTTRIUM Y-90 SILICATE

Marketed by: GE Healthcare Limited
Active ingredient: Yttrium[90Y]-silicatum
Other information: suspension for injection - 92.5 MBq/ml

Available in: Finland
Language: English
Source: Fimea

YTTRIUM Y-90 SILICATE

YTTRIUM Y-90 SILICATE

Marketed by: GE Healthcare Limited
Active ingredient: Yttrium[90Y]-silicatum
Other information: suspension for injection - 370 MBq/ml

Available in: Finland
Language: English
Source: Fimea

YASMIN

YASMIN

Marketed by: Orifarm Oy
Active ingredient: Ethinylestradiolum,Drospirenonum
Other information: film-coated tablet

Available in: Finland
Language: English
Source: Fimea

YANTIL

YANTIL

Marketed by: Grünenthal GmbH
Active ingredient: Tapentadoli hydrochloridum
Other information: film-coated tablet - 50 mg

Available in: Finland
Language: English
Source: Fimea

YANTIL

YANTIL

Marketed by: Grünenthal GmbH
Active ingredient: Tapentadoli hydrochloridum
Other information: film-coated tablet - 75 mg

Available in: Finland
Language: English
Source: Fimea

YANTIL

YANTIL

Marketed by: Grünenthal GmbH
Active ingredient: Tapentadoli hydrochloridum
Other information: film-coated tablet - 100 mg

Available in: Finland
Language: English
Source: Fimea

YANTIL DEPOT

YANTIL DEPOT

Marketed by: Grünenthal GmbH
Active ingredient: Tapentadoli hydrochloridum
Other information: prolonged-release tablet - 50 mg

Available in: Finland
Language: English
Source: Fimea

YANTIL DEPOT

YANTIL DEPOT

Marketed by: Grünenthal GmbH
Active ingredient: Tapentadoli hydrochloridum
Other information: prolonged-release tablet - 100 mg

Available in: Finland
Language: English
Source: Fimea

YANTIL DEPOT

YANTIL DEPOT

Marketed by: Grünenthal GmbH
Active ingredient: Tapentadoli hydrochloridum
Other information: prolonged-release tablet - 150 mg

Available in: Finland
Language: English
Source: Fimea

YANTIL DEPOT

YANTIL DEPOT

Marketed by: Grünenthal GmbH
Active ingredient: Tapentadoli hydrochloridum
Other information: prolonged-release tablet - 200 mg

Available in: Finland
Language: English
Source: Fimea

YANTIL DEPOT

YANTIL DEPOT

Marketed by: Grünenthal GmbH
Active ingredient: Tapentadoli hydrochloridum
Other information: prolonged-release tablet - 250 mg

Available in: Finland
Language: English
Source: Fimea

YELLOW FEVER VACCINE

YELLOW FEVER VACCINE

Marketed by: Connaught Laboratories Inc.
Active ingredient:
Other information: powder for injection

Available in: Finland
Language: English
Source: Fimea

YANTIL Film Coated Tablet 50 Milligram

YANTIL Film Coated Tablet 50 Milligram

Marketed by: Grunenthal Ltd
Active ingredient: TAPENTADOL HYDROCHLORIDE EQUIVALENT TO FREE BASE
Other information: Film Coated Tablet - 50 Milligram

Available in: Ireland
Language: English
Source: HPRA - Health Products Regulatory Authority - Ireland

YANTIL Film Coated Tablet 75 Milligram

YANTIL Film Coated Tablet 75 Milligram

Marketed by: Grunenthal Ltd
Active ingredient: TAPENTADOL HYDROCHLORIDE EQUIVALENT TO FREE BASE
Other information: Film Coated Tablet - 75 Milligram

Available in: Ireland
Language: English
Source: HPRA - Health Products Regulatory Authority - Ireland

YANTIL Film Coated Tablet 100 Milligram

YANTIL Film Coated Tablet 100 Milligram

Marketed by: Grunenthal Ltd
Active ingredient: TAPENTADOL HYDROCHLORIDE EQUIVALENT TO FREE BASE
Other information: Film Coated Tablet - 100 Milligram

Available in: Ireland
Language: English
Source: HPRA - Health Products Regulatory Authority - Ireland

YANTIL SR

YANTIL SR

Marketed by: Grunenthal Ltd
Active ingredient: TAPENTADOL HYDROCHLORIDE EQUIVALENT TO FREE BASE
Other information: Tablet Prolonged Release - 50 Milligram

Available in: Ireland
Language: English
Source: HPRA - Health Products Regulatory Authority - Ireland

YANTIL SR

YANTIL SR

Marketed by: Grunenthal Ltd
Active ingredient: TAPENTADOL HYDROCHLORIDE EQUIVALENT TO FREE BASE
Other information: Tablet Prolonged Release - 100 Milligram

Available in: Ireland
Language: English
Source: HPRA - Health Products Regulatory Authority - Ireland

YANTIL SR

YANTIL SR

Marketed by: Grunenthal Ltd
Active ingredient: TAPENTADOL HYDROCHLORIDE EQUIVALENT TO FREE BASE
Other information: Tablet Prolonged Release - 150 Milligram

Available in: Ireland
Language: English
Source: HPRA - Health Products Regulatory Authority - Ireland

YANTIL SR

YANTIL SR

Marketed by: Grunenthal Ltd
Active ingredient: TAPENTADOL HYDROCHLORIDE EQUIVALENT TO FREE BASE
Other information: Tablet Prolonged Release - 200 Milligram

Available in: Ireland
Language: English
Source: HPRA - Health Products Regulatory Authority - Ireland